Literature DB >> 28871425

miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.

M Kang1, Y Li1, Y Zhao1, S He2, J Shi3.   

Abstract

BACKGROUND: Lung cancer continues to be one of the top five causes of cancer-related mortality. This study aims to identify down- and upregulated miRNAs and mRNA which can be used as potential biomarkers and/or therapeutic targets for lung cancer.
METHODS: Integrated analysis of differential expression profiles of miRNA and mRNA in lung cancer was performed by searching Gene Expression Omnibus datasets. Based on miRNA expression profiles, direct mRNA targets of miRNAs with experimental support were identified through miRTarBase. The levels of representative miRNAs and mRNAs were confirmed through qualitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR).
RESULTS: The miR-33a was decreased in non-small cell lung cancer (NSCLC) tissues compared with the para-carcinoma tissues, whereas its target mRNA of cullin-associated NEDD8-dissociated protein 1 (CAND1) was increased in NSCLC tissues. Further research has shown that miR-33a can inhibit lung cancer cell proliferation, cell cycle progression, and migration by targeting CAND1. Moreover, the CAND1 knockout lung cancer cells showed similar results as cells transfected with miR-33a mimic.
CONCLUSIONS: These results suggested that the data mining based on online databases was an effective method in finding novel target in cancer research, and the miR-33a and CAND1 played an important role in lung cancer proliferation and cell migration.

Entities:  

Keywords:  CAND1; Data mining; Lung cancer; miR-33a

Mesh:

Substances:

Year:  2017        PMID: 28871425     DOI: 10.1007/s12094-017-1730-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Targeting apoptosis pathways in lung cancer.

Authors:  Milind M Pore; T Jeroen N Hiltermann; Frank A E Kruyt
Journal:  Cancer Lett       Date:  2010-10-25       Impact factor: 8.679

3.  CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer.

Authors:  Nina Korzeniewski; Markus Hohenfellner; Stefan Duensing
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

Review 4.  Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer.

Authors:  Yusuf Tutar; Aykut Özgür; Esen Tutar; Lütfi Tutar; Alessandra Pulliero; Alberto Izzotti
Journal:  Biomed Pharmacother       Date:  2016-08-20       Impact factor: 6.529

5.  Plasma microRNAs as novel biomarkers for early detection of lung cancer.

Authors:  Dali Zheng; Shadi Haddadin; Yong Wang; Li-Qun Gu; Michael C Perry; Carl E Freter; Michael X Wang
Journal:  Int J Clin Exp Pathol       Date:  2011-08-08

6.  HIFs-MiR-33a-Twsit1 axis can regulate invasiveness of hepatocellular cancer cells.

Authors:  X-F Guo; A-Y Wang; J Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-07       Impact factor: 3.507

7.  Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Authors:  A Markou; I Sourvinou; P A Vorkas; G M Yousef; E Lianidou
Journal:  Lung Cancer       Date:  2013-06-10       Impact factor: 5.705

8.  Lung Cancer: Are we up to the Challenge?

Authors:  Luca Esposito; Daniele Conti; Ramyasri Ailavajhala; Nansie Khalil; Antonio Giordano
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

9.  MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.

Authors:  Haibing Xiao; Jin Zeng; Heng Li; Ke Chen; Gan Yu; Junhui Hu; Kun Tang; Hui Zhou; Qihong Huang; Anping Li; Yi Li; Zhangqun Ye; Ji Wang; Hua Xu
Journal:  Oncotarget       Date:  2015-05-30

10.  Transcriptional factor FOXO3 negatively regulates the expression of nm23-H1 in non-small cell lung cancer.

Authors:  Linlin Zhang; Lin Li; Huijun Wei; Lili Guo; Cheng Ai; Hongyu Xu; Zhihao Wu; Qinghua Zhou
Journal:  Thorac Cancer       Date:  2015-06-16       Impact factor: 3.500

View more
  9 in total

1.  Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells.

Authors:  Zhihui Che; Fuchen Liu; Wenli Zhang; Mary McGrath; Daisen Hou; Ping Chen; Chunhua Song; Dongqin Yang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 2.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

3.  Identification of differentially distributed gene expression and distinct sets of cancer-related genes identified by changes in mean and variability.

Authors:  Aedan G K Roberts; Daniel R Catchpoole; Paul J Kennedy
Journal:  NAR Genom Bioinform       Date:  2022-01-14

4.  Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.

Authors:  Xinyu Tian; Jie Ma; Ting Wang; Jie Tian; Yue Zhang; Lingxiang Mao; Huaxi Xu; Shengjun Wang
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

5.  A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.

Authors:  Jinchang Pan; Chengwei Zhou; Xiaodong Zhao; Jinxian He; Hui Tian; Weiyu Shen; Ying Han; Jun Chen; Shuai Fang; Xiaodan Meng; Xiaofeng Jin; Zhaohui Gong
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

6.  RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells.

Authors:  Yousef G Amaar; Mark E Reeves
Journal:  Oncotarget       Date:  2019-01-04

7.  miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.

Authors:  Kehua Jiang; Fa Sun; Jianguo Zhu; Guangheng Luo; Yong Ban; Peng Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-06-28       Impact factor: 2.183

8.  Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer.

Authors:  Anna Gogleva; Dimitris Polychronopoulos; Matthias Pfeifer; Vladimir Poroshin; Michaël Ughetto; Matthew J Martin; Hannah Thorpe; Aurelie Bornot; Paul D Smith; Ben Sidders; Jonathan R Dry; Miika Ahdesmäki; Ultan McDermott; Eliseo Papa; Krishna C Bulusu
Journal:  Nat Commun       Date:  2022-03-29       Impact factor: 14.919

Review 9.  The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer.

Authors:  Michał Szczyrek; Paulina Bitkowska; Marta Jutrzenka; Janusz Milanowski
Journal:  J Pers Med       Date:  2022-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.